https://piramalpharma.com

Piramal Pharmamanufacturing, portfolio, critical carePiramal Pharma Limited (PPL) offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries.Piramal Pharma Home About Us Overview Values Board of directors Management team Businesses Pharma Solutions Critical Care Consumer Products AbbVie Therapeutics India Private Limited Investors Financial Reports Corporate Governance Shareholder Information Investor Contacts Disclosure Regulation 46 Of SEBI LODR Investor Day Sustainability News and Media In the News Press Releases Videos Careers Contact Us DOING WELL & DOING GOOD. Making a Positive Difference Serving Patients Living our Values Making a Positive Difference About Us Piramal Pharma Limited (PPL) offers a portfolio of differentiated products and services through its 17 global development and manufacturing facilities and a global distribution network in over 100 countries. Piramal Pharma Limited includes Piramal Pharma Solutions (PPS), an integrated Contract Development and Manufacturing Organization, Piramal Critical Care (PCC), a Complex Hospital Generics business; and the India Consumer Healthcare business, selling over-the-counter products. KNOW MORE Businesses Pharma Solutions Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle, serving customers through a globally integrated network of facilities in North America, Europe, and Asia. KNOW MORE Critical Care Piramal Critical Care (PCC) is a leading, global player in inhaled anesthetics hospital generics, maintaining a wide presence across the USA, Europe and more than 100 countries worldwide. KNOW MORE Consumer Products Piramal Consumer Products Division (CPD) is one of the fastest-growing businesses of Piramal Pharma Limited. It is among the leading players in the Indian self-care space, with established brands like Littles, Lacto Calamine, i-pill, Tetmosol. Polycrol and Tri-Activ, among others, in the Indian Consumer Healthcare market. KNOW MORE AbbVie Therapeutics India Private Limited AbbVie Therapeutics India Private Limited (formerly Allergan India Pvt Ltd), a joint venture between Allergan (now part of AbbVie) and Piramal Pharma Limited, commenced commercial operations in 1996 and has emerged as the market leader in the fast-growing ophthalmic category with the successful launches of a series of high technology medication and devices for diseases such as glaucoma, dry eye, infections, and inflammations. Latest At Piramal Pharma Nandini Piramal in conversation with Bloomberg TV Read More PPL Investor Day – Financial Aspirations Read More Piramal Pharma releases its Sustainability Report for FY 2023-24 Read More PPS Lexington’s $80M investment plan for expansion Read More Rashida Najmi on Anti-body Drug Conjugates (ADCs) in Pharma Horizon – Biologics report. Read More PPL Investor Day Highlights Read More The Economic Times - Piramal Pharma aims for $2-b annual sales by 2030 Read More Piramal Pharma aims to be over USD 2bn entity by FY30: Chairperson Nandini Piramal Read More Nandini Piramal details 5-year growth strategy, expects strong profit growth this year Read More World Patient Safety Day Read More Piramal Pharma’s GHG Commitment Validated and Approved by SBTi Read More PPL Digwal, India site honoured for its impactful CSR efforts Read More Puneet Rajput, CHRO, PPL talks about the AI evolution in employee experience at People Matter’s TechHR event in Delhi. Read More Budget 2024 : Experts advocate for boosting investment, incentivised schemes, and preventive healthcare Read More PPL recognised at ET Now’s Best Organisation for Women Awards. Read More US Biosecure Act may boost Indian CDMO, CRO firms Read More Piramal Pharma's tech-led business transformation journey. Read More Enabling Innovation Empowering Tomorrow Read More Narmada Riverbank Cleaning Activity at Dahej. Read More To learn more about Piramal Group KNOW MORE Follow Us On About Us Overview Board of Directors Management Team Businesses Pharma Solutions Critical Care Consumer Products AbbVie Therapeutics India Private Limited Investors Financial Reports Corporate Governance Shareholder Information Investor Contacts Disclosure Regulation 46 Of SEBI LODR Investor Day News and Media In the News Press Releases SUSTAINABILITY Careers Contact Us © 2024 Piramal Pharma Limited. All Rights Reserved. Privacy Policy Disclaimerenen1728350101https://piramalpharma.com

לערוך את האתר שלך?

מה אתה עושה?